11 completed, 5 recruiting, 3 unknown, 1 terminated. 20 Phase 2, 4 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 20 | Completed 11, Recruiting 5, Unknown 3, Terminated 1 |
| Phase 1 | 4 | Unknown 2, Completed 1, Recruiting 1 |
| Phase 3 | 4 | Completed 3, Unknown 1 |
Follow Acute Pancreatitis: new trials by email Literature Review of Acute Pancreatitis trials Research Report on Acute Pancreatitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of SGC001 Injection for Predicted Severe Acute Pancreatitis to Assess Safety, Tolerability and Preliminary Efficacy SGC001 injection, Placebo - Acute Pancreatitis | Phase 2 | Recruiting | Beijing Sungen Biomedical Technology Co., Ltd | 129 | 2026-09-30 | 2026-10-13 |
| A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis RABI-767 - Acute Pancreatitis | Phase 2 | Recruiting | Panafina, Inc. | 36 | 2024-06-28 | 2026-08-05 |
| Prophylactic Tributyrin Supplementation in Acute Pancreatitis Micro-encapsulated granules of tributyrin (intervention), Micro-encapsulated granules of sunflower oil (placebo) - Acute Pancreatitis | Phase 2 | Recruiting | St. Antonius Hospital | 92 | 2024-02-12 | 2024-06-20 |
| Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid Ketorolac, Opioid - Acute Pancreatitis | Phase 2 | Terminated | Boston Children's Hospital | 23 | 2022-03-15 | 2026-01-08 |
| Effects of Peripherally Acting µ-opioid Receptor Antagonists on Acute Pancreatitis Placebo treatment, Methylnaltrexone treatment - Acute Pancreatitis | Phase 2 / Phase 3 | Completed | Asbjørn Mohr Drewes | 105 | 2021-05-14 | 2023-04-21 |
| A Study of Auxora in Patients With Acute Pancreatitis and Accompanying SIRS CM-4620 Injectable Emulsion or CM-4620-IE, Placebo - Acute Pancreatitis, Systemic Inflammatory Response Syndrome | Phase 2 | Completed | CalciMedica, Inc. | 216 | 2021-03-24 | 2026-08-24 |
| Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase CM4620 - Acute Pancreatitis | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 42 | 2020-09-04 | 2026-06-03 |
| Randomised Treatment of Acute Pancreatitis With Infliximab: Double-blind, Placebo-controlled, Multi-centre Trial (RAPID-I) Infusion of 5 mg/kg Infliximab, Infusion of 10 mg/kg Infliximab, 0.9% Sodium Chloride (Placebo) - Acute Pancreatitis | Phase 2 | Recruiting | University of Liverpool | 240 | 2019-05-01 | 2026-07-06 |
| A PK/PD Study of CM4620-IE in Patients With Acute Pancreatitis CM4620-IE - Acute Pancreatitis | Phase 2 | Completed | CalciMedica, Inc. | 7 | 2019-01-06 | 2022-05-03 |
| CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS CM4620 Injectable Emulsion (Low Dose), CM4620 Injectable Emulsion (High Dose) - Acute Pancreatitis, Systemic Inflammatory Response Syndrome | Phase 2 | Completed | CalciMedica, Inc. | 21 | 2018-03-12 | 2026-03-30 |
| Fecal Microbiota Transplantation for Pancreatitis Fecal Microbiota Transplantation, normal saline - Acute Pancreatitis, Intestinal Bacteria Flora Disturbance | Phase 2 | Completed | The First Affiliated Hospital of Nanchang University | 60 | 2017-11-18 | 2021-04-14 |
| Fecal Microbiota Transplantation (FMT) for Severe Acute Pancreatitis(SAP) Fecal Microbiota Transplantation, normal saline - Acute Pancreatitis, Intestinal Bacteria Flora Disturbance | Phase 1 / Phase 2 | Unknown | First Affiliated Hospital of Chengdu Medical College | 80 | 2016-12-01 | 2017-01-11 |
| Simvastatin in Reducing Pancreatitis in Patients With Recurrent, Acute or Chronic Pancreatitis Laboratory Biomarker Analysis, Placebo Administration, Quality-of-Life Assessment - Acute Pancreatitis | Phase 2 | Completed | National Cancer Institute (NCI) | 8 | 2016-09-19 | 2022-12-13 |
| Enhanced Recovery in Acute Pancreatitis Enhanced recovery protocol - Acute Pancreatitis | Phase 2 | Completed | Kaiser Permanente | 46 | 2016-06-01 | 2017-05-30 |
| Epidural Anesthesia in Acute Pancreatitis Epidural anesthesia, intravenous analgesia - Acute Pancreatitis | Phase 2 / Phase 3 | Unknown | Hospital General Naval de Alta Especialidad - Escuela Medico Naval | 60 | 2015-11-01 | 2016-01-11 |
| Neostigmine Treatment of Acute Pancreatitis Combined With Intra-abdominal Hypertension Neostigmine Methylsulfate 1 MG/ML, Conservative treatment - Acute Pancreatitis, Intra-abdominal Hypertension | Phase 2 | Completed | The First Affiliated Hospital of Nanchang University | 80 | 2015-09-01 | 2021-10-05 |
| The Clinical Study of Acute Pancreatitis Treated by TongFuSan TongFuSan - Acute Pancreatitis | Phase 1 / Phase 2 | Unknown | Beijing Friendship Hospital | 100 | 2014-03-01 | 2014-07-30 |
| Use of Streptokinase for Enhancement of Percutaneous Drainage of Pancreatic Necrosis streptokinase, Saline irrigation - Acute Pancreatitis | Phase 2 / Phase 3 | Completed | Post Graduate Institute of Medical Education and Research, Chandigarh | 28 | 2013-05-01 | 2016-07-07 |
| Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics Meropenem - Acute Pancreatitis | Phase 1 / Phase 2 | Completed | Benazir Bhutto Hospital, Rawalpindi | 90 | 2013-01-01 | 2014-08-08 |
| MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA) Enteral tube feeding - Acute Pancreatitis | Phase 2 / Phase 3 | Completed | University of Auckland, New Zealand | 35 | 2010-05-01 | 2013-01-08 |
Pancreatitis (20) · Systemic Inflammatory Response Syndrome (2) · Agnosia (1) · Intra-Abdominal Hypertension (1) · Pancreatitis, Acute Necrotizing (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
Digestive System Diseases (20) · Pancreatic Diseases (20) · Pathological Conditions, Signs and Symptoms (3) · Inflammation (2) · Pathologic Processes (2) · Shock (2) · Cardiovascular Diseases (1) · Compartment Syndromes (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia (1) · Leukemia, Lymphoid (1) · Lymphatic Diseases (1)
Fecal Microbiota Transplantation (2) · Saline Solution (2) · zegocractin (2) · Analgesics, Opioid (1) · Anesthesia, Epidural (1) · Conservative Treatment (1) · Enteral Nutrition (1) · Hydromorphone (1) · Infliximab (1) · Ketorolac (1) · Ketorolac Tromethamine (1) · Meropenem (1) · Methods (1) · Morphine (1) · Neostigmine (1)
CalciMedica, Inc. (3) · The First Affiliated Hospital of Nanchang University (2) · Asbjørn Mohr Drewes (1) · Beijing Friendship Hospital (1) · Beijing Sungen Biomedical Technology Co., Ltd (1) · Benazir Bhutto Hospital, Rawalpindi (1) · Boston Children's Hospital (1) · First Affiliated Hospital of Chengdu Medical College (1) · Hospital General Naval de Alta Especialidad - Escuela Medico Naval (1) · Kaiser Permanente (1) · National Cancer Institute (NCI) (1) · Panafina, Inc. (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · St. Antonius Hospital (1) · St. Jude Children's Research Hospital (1)
United States (8) · China (5) · India (3) · Denmark (1) · Mexico (1) · Netherlands (1) · New Zealand (1) · Pakistan (1) · United Kingdom (1)
Sudarshan Hebbar, MD (3) · Nonghua Lv, MD (2) · Amit Grover, MB BCh BAO (1) · Aurora Guadalupe Ruiz Sandoval, anesthesia (1) · Bechien U Wu, MD, MPH (1) · Bilal Altaf, MBBS, FCPS I (1) · Bin Miao, PHD (1) · Chao Wang, PHD (1) · Dinghua Xu, graduate (1) · Fazal H Shah, MBBS, FCPS I (1) · Fengwu Li, graduate (1) · H. C. van Santvoort, dr. prof. (1) · Hong Wang, Graduate (1) · Li Fang, Ph.D (1)
PMID 16521220, PMID 18191686, PMID 18388680, PMID 20012652, PMID 21562445, PMID 23340042, PMID 24054878, PMID 25685727, PMID 30629020, PMID 33939666, PMID 34924020, PMID 35083238, PMID 35241135, PMID 38916223, PMID 41938843, PMID 42760074, PMID 9539611
2017 (1), N01CN00035 (1), P30CA060553 (1)